Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
1.
BJU Int ; 124(1): 124-133, 2019 07.
Artículo en Inglés | MEDLINE | ID: mdl-30589205

RESUMEN

OBJECTIVES: To evaluate the effectiveness of a web-based decision aid (DA), with values clarification exercises compared with usual care, for men with lower urinary tract symptoms due to benign prostatic hyperplasia (LUTS/BPH). PATIENTS AND METHODS: Between July 2016 and January 2017, all new patients with LUTS/BPH who consulted the urologist were invited to use the DA and participate in this prospective questionnaire study. Patients who consulted the urologist between December 2015 and February 2016 served as controls. The DA was designed to support patients in making a well-informed treatment decision, corresponding with their personal preferences and values. Well-informed decision was measured by using a knowledge questionnaire. Value congruent decision was measured by the correspondence between responses on nine value statements and chosen treatment. The primary outcome, decision quality, was defined as the combination of well-informed decision and value congruent decision. Secondary outcomes were decisional conflict, involvement and received role in shared decision-making, decisional regret, and treatment choice. RESULTS: A total of 109 DA-users and 108 controls were included. DA-users were younger (68.4 vs 71.5 years; P = 0.003) and their education level was higher (P = 0.047) compared with the controls. Patients who used the DA made a well-informed and value congruent decision more often than the control group (43% vs 21%; P = 0.028). DA-users had less decisional conflict (score 33.2 vs 46.6; P = 0.003), experienced a less passive role in decision-making (22% vs 41%; P = 0.038), and reported less process regret (score 2.4 vs 2.8; P = 0.034). Furthermore, DA-users who had not used prior medication chose lifestyle advices more often than the control group (43% vs 11%; P = 0.002). Outcomes were adjusted for significantly different baseline characteristics. CONCLUSION: The LUTS/BPH DA seems to improve the decision quality by supporting patients in making more well-informed and value congruent treatment decisions. Therefore, further implementation of this DA into routine care is suggested.


Asunto(s)
Técnicas de Apoyo para la Decisión , Internet , Síntomas del Sistema Urinario Inferior/etiología , Síntomas del Sistema Urinario Inferior/terapia , Hiperplasia Prostática/complicaciones , Hiperplasia Prostática/terapia , Anciano , Toma de Decisiones , Humanos , Masculino , Persona de Mediana Edad , Participación del Paciente , Prioridad del Paciente , Estudios Prospectivos , Encuestas y Cuestionarios
2.
Urology ; 137: 138-145, 2020 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-31899227

RESUMEN

OBJECTIVE: To evaluate treatment preferences of patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH) before and after using a web-based decision aid (DA). PATIENTS AND METHODS: Between July 2016 and January 2017 patients were invited to use a web-based LUTS/BPH DA. Treatment preferences (for lifestyle advices, medication or surgery) before and after DA use and responses on values clarification exercises were extracted from the DA. RESULTS: In total, 126 patients were included in the analysis. Thirty-four percent (43/126) had not received any previous treatment and were eligible for (continuation of) lifestyle advices or to start medication, as initial treatment. The other 66% (83/126) did use medication and were eligible, either for continuing medication or to undergo surgery. Before being exposed to the DA, 67 patients (53%) were undecided and 59 patients (47%) indicated an initial treatment preference. Half of the patients who were initially undecided were able to indicate a preference after DA use (34/67, 51%). Of those with an initial preference, 80% (47/59) confirmed their initial preference after DA use. Five out of 7 values clarification exercises used in the DA were discriminative between final treatment preferences. In 79%, the treatment preferred after DA use matched the received treatment. Overall, healthcare providers were positive about DA feasibility. CONCLUSION: Our findings suggest that a LUTS/BPH DA may help patients to confirm their initial treatment preference and support them in forming a treatment preference if they did not have an initial preference.


Asunto(s)
Toma de Decisiones , Técnicas de Apoyo para la Decisión , Intervención basada en la Internet , Síntomas del Sistema Urinario Inferior , Prioridad del Paciente/estadística & datos numéricos , Hiperplasia Prostática , Calidad de Vida , Anciano , Tratamiento Conservador/métodos , Tratamiento Conservador/psicología , Humanos , Estilo de Vida , Síntomas del Sistema Urinario Inferior/etiología , Síntomas del Sistema Urinario Inferior/psicología , Síntomas del Sistema Urinario Inferior/terapia , Masculino , Persona de Mediana Edad , Países Bajos , Evaluación de Resultado en la Atención de Salud , Hiperplasia Prostática/patología , Hiperplasia Prostática/fisiopatología , Hiperplasia Prostática/psicología , Hiperplasia Prostática/terapia , Procedimientos Quirúrgicos Operativos/métodos , Procedimientos Quirúrgicos Operativos/psicología , Encuestas y Cuestionarios , Espera Vigilante
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda